Parenteral protein-based rotavirus vaccine
- PMID: 28483417
- PMCID: PMC7218797
- DOI: 10.1016/S1473-3099(17)30244-X
Parenteral protein-based rotavirus vaccine
Comment on
-
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.Lancet Infect Dis. 2017 Aug;17(8):843-853. doi: 10.1016/S1473-3099(17)30242-6. Epub 2017 May 5. Lancet Infect Dis. 2017. PMID: 28483414 Free PMC article. Clinical Trial.
Similar articles
-
Single-dose rotavirus vaccine at birth: is it effective or safe?Lancet Infect Dis. 2018 Sep;18(9):948. doi: 10.1016/S1473-3099(18)30467-5. Lancet Infect Dis. 2018. PMID: 30152362 No abstract available.
-
Can Changes to Scheduling Enhance the Performance of Rotavirus Vaccines in Low-Income Countries?J Infect Dis. 2016 Jun 1;213(11):1673-5. doi: 10.1093/infdis/jiw026. Epub 2016 Jan 27. J Infect Dis. 2016. PMID: 26823336 No abstract available.
-
Single-dose rotavirus vaccine at birth: is it effective or safe? - Authors' reply.Lancet Infect Dis. 2018 Sep;18(9):948-949. doi: 10.1016/S1473-3099(18)30487-0. Lancet Infect Dis. 2018. PMID: 30152361 No abstract available.
-
[Rotavirus vaccination in Europe in 2010].Bull Acad Natl Med. 2010 Nov;194(8):1451-62; discussion 1462-4. Bull Acad Natl Med. 2010. PMID: 22046709 Review. French.
-
The future of rotavirus vaccines.Semin Pediatr Infect Dis. 2002 Jul;13(3):190-5. doi: 10.1053/spid.2002.125862. Semin Pediatr Infect Dis. 2002. PMID: 12199615 Review.
Cited by
-
Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges.Vaccines (Basel). 2024 Jun 3;12(6):609. doi: 10.3390/vaccines12060609. Vaccines (Basel). 2024. PMID: 38932338 Free PMC article.
-
Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine.J Pharm Sci. 2020 Jan;109(1):394-406. doi: 10.1016/j.xphs.2019.08.001. Epub 2019 Aug 7. J Pharm Sci. 2020. PMID: 31400346 Free PMC article.
-
Rotavirus vaccines: why continued investment in research is necessary.Curr Clin Microbiol Rep. 2018 Mar;5(1):73-81. Epub 2018 Jan 18. Curr Clin Microbiol Rep. 2018. PMID: 29805958 Free PMC article.
-
Rotavirus Vaccines: a story of success with challenges ahead.F1000Res. 2017 Aug 18;6:1517. doi: 10.12688/f1000research.11912.1. eCollection 2017. F1000Res. 2017. PMID: 28928954 Free PMC article. Review.
-
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.Drug Saf. 2022 Feb;45(2):155-168. doi: 10.1007/s40264-021-01141-4. Epub 2022 Jan 11. Drug Saf. 2022. PMID: 35015268 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48: 1007. - PubMed
-
- Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11–22. - PubMed
-
- Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical